Cvijic Christine Mikail (CIK 1543663) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-07). Recent activity: Sell NGNE (600 shares), Sell NGNE (4,200 shares), Sell NGNE (739 shares), Sell NGNE (2,531 shares), Sell NGNE (1,530 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | Neurogene Inc. (NGNE) | President and CFO | Sell | 600 | $21,613 |
| 2026-07-07 | Neurogene Inc. (NGNE) | President and CFO | Sell | 4,200 | $151,763 |
| 2026-07-02 | Neurogene Inc. (NGNE) | President and CFO | Sell | 739 | $25,170 |
| 2026-07-02 | Neurogene Inc. (NGNE) | President and CFO | Sell | 2,531 | $87,519 |
| 2026-07-02 | Neurogene Inc. (NGNE) | President and CFO | Sell | 1,530 | $53,897 |
| 2026-05-08 | Neurogene Inc. (NGNE) | President and CFO | Sell | 4,800 | $144,336 |
| 2026-05-08 | Neurogene Inc. (NGNE) | President and CFO | Sell | 4,800 | $155,712 |
| 2026-03-30 | Neurogene Inc. (NGNE) | President and CFO | Sell | 2,558 | $55,304 |
| 2026-03-17 | Neurogene Inc. (NGNE) | President and CFO | Sell | 2,387 | $48,743 |
| 2026-03-17 | Neurogene Inc. (NGNE) | President and CFO | Sell | 1,395 | $29,644 |
| 2026-03-17 | Neurogene Inc. (NGNE) | President and CFO | Sell | 263 | $5,791 |
| 2026-03-03 | Neurogene Inc. (NGNE) | President and CFO | Sell | 4,800 | $120,528 |
| 2026-02-24 | Neurogene Inc. (NGNE) | President and CFO | Buy | 22,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-07-07